Literature DB >> 6184548

Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.

D Drafta, E Proca, V Zamfir, A E Schindler, E Neacşu, E Stroe.   

Abstract

Cortisol, 17-hydroxyprogesterone (17-OH-P), progesterone, testosterone, 5 alpha-dihydrotestosterone (DHT), estrone (E1) and estradiol (E2) were determined by RIA after chromatographic separation of steroids on Sephadex LH-20 columns, in 54 hospitalized patients with benign prostatic hyperplasia (BPH) and in 32 hospitalized patients with prostatic carcinoma (PCA) (T34, N01, M01). The patients' values were compared with those of 63 age-matched controls. Increased cortisol and DHT levels, subnormal estrogen and 17-OH-P values and normal progesterone level were found in both benign and malignant groups. Higher mean values for testosterone, and T/DHT ratio and lower mean values for E2/T ratio were found in PCA, as compared with those in BPH. An age invariance of cortisol, testosterone, T/DHT ratio and estradiol was found in both BPH and PCA, instead of the age dependence found in normal subjects. The normal relations between testosterone and its precursor (17-OH-P) and its peripheral metabolite (E2), respectively, and the normal relation between estrone and 17-OH-P were not evident in either BPH or PCA group. The normal direct relation between testosterone and DHT has been found in both patient groups.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184548     DOI: 10.1016/0022-4731(82)90572-6

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  6 in total

1.  Perinatal characteristics in relation to incidence of and mortality from prostate cancer.

Authors:  A Ekbom; C C Hsieh; L Lipworth; A Wolk; J Pontén; H O Adami; D Trichopoulos
Journal:  BMJ       Date:  1996-08-10

2.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

Review 3.  [Testosterone and the prostate].

Authors:  H Sperling; R Rossi; G Lümmen; H Rübben
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

4.  Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men.

Authors:  G D Honda; L Bernstein; R K Ross; S Greenland; V Gerkins; B E Henderson
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

5.  Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study.

Authors:  S O Andersson; H O Adami; R Bergström; L Wide
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

Review 6.  Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.

Authors:  Nguyen Hoang Anh; Nguyen Phuoc Long; Sun Jo Kim; Jung Eun Min; Sang Jun Yoon; Hyung Min Kim; Eugine Yang; Eun Sook Hwang; Jeong Hill Park; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolites       Date:  2019-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.